Skip to main
UHS
UHS logo

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 25%
Hold 50%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services Inc. has experienced notable financial growth, with the Acute Care Hospital Services segment achieving a same-store adjusted EBITDA margin expansion of 190 basis points to 15.8% and a revenue increase of 12.8%. The Behavioral Health Services segment also saw a growth in same-store revenue of 9.3%, with adjusted patient days rising 1.3% year-over-year, indicating a positive trend in patient demand and service utilization. Furthermore, anticipated benefits from pending CMS program approvals and the company's outlook for 2026 highlight strong pricing power and revenue growth prospects, further enhancing the positive outlook for the company's financial performance.

Bears say

Universal Health Services Inc. faces a challenging financial outlook, attributed primarily to headwinds in volume and margin, leading to projected earnings about 5% below earlier estimates for FY26, along with an enterprise multiple reflecting trough levels. Projections indicate declining contributions from the behavioral health segment, with expected EBITDA impacts between $420 million and $470 million over the period from 2028 to 2032 as growth rates are revised downward. Additionally, risks such as potential regulatory changes, a high concentration in the Las Vegas market, and labor supply constraints may further hinder the company's profitability and operational efficiency.

UHS has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 12 analysts, UHS has a Hold consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $233.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $233.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.